HTA is the examination of the long term impact of a health technology. This assessment is carried out by independent bodies. HTA produces a recommendation through the demonstrated financial savings and added value for patients.
STA-Liatest D-Dimer Plus and D-dimer testing in patient care pathways generates real savings removing the need of up to 45% of complementary imaging which can be unnecessary, costly, invasive and a source of anxiety for patients
To learn more please watch the video below
Health Technology Assessment (HTA) involves a range of processes and mechanisms that use scientific evidence to assess the quality, safety, efficacy, effectiveness and cost effectiveness of health services. HTA is a way to be sure our technologies bring value to healthcare systems and their users
Stago has set itself the mission of improving patient care in the most cost-effective manner.
Stago contracted with Alira Health to conduct an economic evaluation comparing the use of the STA-Liatest D-Di assay in conjunction with a probability assessment model to other D-dimers.
Learn more with the link below or contact us: email@example.com